Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Trading Down 5.4% Following Insider Selling

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s share price traded down 5.4% during trading on Thursday after an insider sold shares in the company. The stock traded as low as $47.50 and last traded at $47.77, with a volume of 1,958,998 shares traded. The stock had previously closed at $50.50.

Specifically, Director Reeve B. Waud sold 724,694 shares of Acadia Healthcare stock in a transaction that occurred on Wednesday, June 14th. The stock was sold at an average price of $45.53, for a total transaction of $32,995,317.82. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Ronald Morgan Fincher sold 86,483 shares of Acadia Healthcare stock in a transaction that occurred on Monday, May 1st. The shares were sold at an average price of $44.43, for a total value of $3,842,439.69. Following the sale, the chief operating officer now directly owns 137,204 shares in the company, valued at $6,095,973.72. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 968,102 shares of company stock worth $44,283,109. Insiders own 11.10% of the company’s stock.

A number of analysts have recently commented on ACHC shares. Jefferies Group LLC reissued a “buy” rating on shares of Acadia Healthcare in a research report on Monday, May 15th. Zacks Investment Research raised Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Friday, March 24th. Cantor Fitzgerald reissued a “hold” rating and issued a $45.00 price target on shares of Acadia Healthcare in a research report on Wednesday, April 26th. Deutsche Bank AG initiated coverage on Acadia Healthcare in a research report on Wednesday, April 5th. They issued a “buy” rating and a $53.00 price objective on the stock. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $51.00 price objective on shares of Acadia Healthcare in a research report on Thursday, June 1st. Three research analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $57.23.

The company has a market capitalization of $4.32 billion, a price-to-earnings ratio of 285.70 and a beta of 1.13. The firm’s 50 day moving average price is $44.67 and its 200 day moving average price is $41.57.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Tuesday, April 25th. The company reported $0.46 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.46. The company had revenue of $679.20 million during the quarter, compared to the consensus estimate of $691.74 million. Acadia Healthcare had a net margin of 0.53% and a return on equity of 8.89%. The firm’s quarterly revenue was up 10.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.55 earnings per share. Equities research analysts predict that Acadia Healthcare Company, Inc. will post $2.45 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently bought and sold shares of ACHC. State Street Corp increased its position in Acadia Healthcare by 2.6% in the fourth quarter. State Street Corp now owns 1,019,537 shares of the company’s stock worth $33,768,000 after buying an additional 26,282 shares in the last quarter. Dimensional Fund Advisors LP increased its position in Acadia Healthcare by 1.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 609,118 shares of the company’s stock worth $20,165,000 after buying an additional 8,635 shares in the last quarter. FMR LLC increased its position in Acadia Healthcare by 223.5% in the fourth quarter. FMR LLC now owns 803,450 shares of the company’s stock worth $26,594,000 after buying an additional 555,106 shares in the last quarter. Guggenheim Capital LLC increased its position in Acadia Healthcare by 637.2% in the fourth quarter. Guggenheim Capital LLC now owns 43,088 shares of the company’s stock worth $1,426,000 after buying an additional 37,243 shares in the last quarter. Finally, Norges Bank acquired a new position in Acadia Healthcare during the fourth quarter worth about $8,410,000.

COPYRIGHT VIOLATION NOTICE: This piece was first reported by Stock Observer and is the sole property of of Stock Observer. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States and international copyright and trademark law. The original version of this piece can be viewed at https://www.thestockobserver.com/2017/07/18/acadia-healthcare-company-inc-nasdaqachc-shares-down-5-4-on-insider-selling-updated.html.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply